Andrews Place, 5th fl
51 Church Street
Hamilton HM 12
Listed Since: 2012/11/26
Delisted on: 2014/07/07
BSX Ticker: REZG5.BH
CUSIP: G7538A106
ISIN: BMG7538A1062
Tel: 1-441-400 4747
Fax: 1-441-236-1999

**Delisted Monday, 07 July, 2014, for failing meet their on-going obligations and conditions required under the BSX Listing Regulations, Section I, Chapter 2, Regulation 2.24(1), (3) & (4). **


RezGen 5, Limited, was originally incorporated under the name NeoMedigen, Inc., in the Province of New Brunswick Canada bearing registration number 664491 on 15 June, 2012. It was continued to Bermuda under NeoMedigen Limited on 24 April, 2013, bearing registration number 47643 and as evidenced by a Certificate of Continuance issued by the Registrar of Companies in Bermuda on 7 May 2013.

RezGen 5, Limited is a Bermuda based biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer’s and cardiovascular diseases. RezGen 5, Limited is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  The company's headquarters are in Hamilton, Bermuda.


BSX Trading History (USD)

Unadjusted For Stock Dividends and Stock Splits



Disclaimer and Privacy Policy    Complaints Policy

Copyright © 2024 by Bermuda Stock Exchange. All rights reserved!

Questions or requests for information can be emailed to